0360-2532
Quarterly
No
DRUG METAB REV
1972
21
UNITED STATES
http://informahealthcare.com/dmr
约稿?周期不定审稿时间
一般平均录用比例
3.8影响因子
药学小学科
92/352JIF RANK
3032总被引频次
月期刊平台服务过的文章录用时间为1-3个月,依据20年经验,经月期刊专家预审通过后的文章,投稿通过率100%以上!
该权威期刊的影响因子为1.818(根据最新的JCR/ISI影响因子排名编制),始终如一地为一系列令人印象深刻的药物代谢研究提供迫切需要的评论——涵盖已建立的、新的和潜在的药物;环境有毒化学物质;吸收;代谢和排泄;以及所有现存物种的酶学。此外,药物代谢综述为不同的医学专业人员提供了新的假说,包括药理学家、毒理学家、化学家、微生物学家、药代动力学家、免疫学家、质谱学家以及从事异种生物转化研究的酶学家。
https://mc.manuscriptcentral.com/ldmr
With an impact factor of 1.818 (as compiled by the latest JCR/ISI Impact Factor Rankings), this authoritative journal consistently provides critically needed reviews of an impressive array of drug metabolism research —covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species. Additionally, Drug Metabolism Reviews offers new hypotheses of interest to diverse group of medical professionals including pharmacologists, toxicologists, chemists, microbiologists, pharmacokineticists, immunologists, mass spectroscopists, as well enzymologists working in xenobiotic biotransformation.